Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Axial spondylometaphyseal dysplasia is a genetic disorder of bone growth. The term axial means towards the center of the body. Sphondylos is a Greek term meaning vertebra. Metaphyseal dysplasia refers to abnormalities at the ends of long bones.Axial spondylometaphyseal dysplasia primarily affects the bones of the chest, pelvis, spine,upper arms and upper legs, and results in shortened stature.For reasons not well understood,this rare skeletal dysplasia is also associated withearly and progressivevision loss. The underlying genetic cause of axial spondylometaphyseal dysplasia is currently unknown.It is thought to be inherited in an autosomal recessive fashion.
Features include always present findings: Rhizomelia, Reduced sperm motility, and Damage to the optic nerve (optic atrophy); and very common findings: Rod-cone dystrophy and Cone/cone-rod dystrophy. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 3 | Proximal femoral metaphyseal irregularity, Short femoral neck, Sideways curvature of the spine (scoliosis) |
CFAP410 encodes cilia and flagella associated protein 410 (256 aa). Plays a role in cilia formation and/or maintenance. Plays a role in the regulation of cell morphology and cytoskeletal organization. Involved in DNA damage repair Highest expression in Thyroid (46.0 TPM) and Pituitary (42.8 TPM).
Axial spondylometaphyseal dysplasia is associated with mutations in the CFAP410 gene on chromosome 21.
CFAP410 is classified as a druggable target with score 0.0.
Genetic testing for CFAP410 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 2 very common features, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for axial spondylometaphyseal dysplasia.
6 publications have been identified in PubMed for axial spondylometaphyseal dysplasia. Research spans Basic Science / Preclinical (67%), Case Report / Case Series (17%), and Epidemiology / Natural History (17%).
Sornthai W (2025). [PMID: 39863786](https://pubmed.ncbi.nlm.nih.gov/39863786/). *Sci Rep*. [Epidemiology / Natural History]
Schmidt RE (2025). [PMID: 40246852](https://pubmed.ncbi.nlm.nih.gov/40246852/). *NPJ Genom Med*. [Basic Science / Preclinical]
Stadler A (2025). [PMID: 40018707](https://pubmed.ncbi.nlm.nih.gov/40018707/). *Front Cell Dev Biol*. [Basic Science / Preclinical]
De Decker M (2025). [PMID: 39703094](https://pubmed.ncbi.nlm.nih.gov/39703094/). *Brain*. [Basic Science / Preclinical]
Borchert GA (2024). [PMID: 39232248](https://pubmed.ncbi.nlm.nih.gov/39232248/). *Ophthalmic Genet*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 12:34 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Eyes |
3 |
Nystagmus, Retinal degeneration, Damage to the optic nerve (optic atrophy) |
Growth and development | 2 | Short stature, Disproportionate short-trunk short stature |
Lungs and breathing | 2 | Recurrent pneumonia, Restrictive ventilatory defect |
Digestive system | 1 | Enlarged spleen (splenomegaly) |
Blood and immune system | 1 | Enlarged spleen (splenomegaly) |
Muscles | 1 | Damage to the optic nerve (optic atrophy) |
Age of onset: childhood.